Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID‐19 patients
Francisco Sandro Menezes Rodrigues, José Gustavo Padrão Tavares, Marcelo Pires de Oliveira, Rafael Guzella de Carvalho, Paolo Ruggero Errante, Murched Omar Taha, Djalma José Fagundes, Afonso Caricati‐Neto
Topics & Concepts
Coronavirus disease 2019 (COVID-19)HeparinMedicineAnticoagulant2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CardiologyInternal medicineVirologyInfectious disease (medical specialty)DiseaseOutbreakCOVID-19 Clinical Research StudiesVenous Thromboembolism Diagnosis and ManagementLong-Term Effects of COVID-19